Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes.
Zucheng XieYan QinXinrui ChenSheng YangJianliang YangLin GuiPeng LiuXiaohui HeShengyu ZhouChanggong ZhangLe TangYuankai ShiPublished in: Targeted oncology (2024)
group correlated with better PFS, which may result from an intricate interplay of immune processes and tumor microenvironment alterations.